Ligand profile
C
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_3750 — translation elongation factor Tu
Identifiers
Database identifiers and provenance.
- Ligand ID
C- PDB
4v5p- UniProt (similar protein)
Q5SHN6- Target protein
- VK055_3750
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 177.4
- −1 ≤ LogP ≤ 5 -2.45
- MW ≤ 500 Da 323.2
- LogP ≤ 5 -2.45
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 177.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)OC1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O
InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1
IERHLVCPSMICTF-XVFCMESISA-NIERHLVCPSMICTF-XVFCMESISA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00276
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand C →
- PDB RCSB structure 4v5p →
- UniProt UniProt Q5SHN6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “C”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3750.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).